Patients with steroid-induced glaucoma may not initially notice any symptoms, as the condition can develop gradually. However, as the disease progresses, they might experience symptoms such as blurred vision, eye pain, headaches, halos around lights, and in severe cases, loss of peripheral vision. It is crucial for patients using corticosteroids to have regular eye examinations to monitor for any changes in IOP.

The workup for suspected steroid-induced glaucoma involves a comprehensive eye examination. Key components include:

• Tonometry: Measures the intraocular pressure to detect any elevation.
• Gonioscopy: Examines the drainage angle of the eye to rule out other types of glaucoma.
• Ophthalmoscopy: Evaluates the optic nerve for any signs of damage.
• Visual Field Test: Assesses peripheral vision to detect any loss.
• Optical Coherence Tomography (OCT): Provides detailed images of the optic nerve and retina to identify any structural changes.

The primary goal of treatment is to lower the intraocular pressure to prevent optic nerve damage. This can be achieved through:

• Discontinuation or Reduction of Steroids: If possible, reducing the dose or switching to a non-steroidal alternative can help.
• Medications: Eye drops such as beta-blockers, prostaglandin analogs, or carbonic anhydrase inhibitors may be prescribed to lower IOP.
• Laser Therapy or Surgery: In cases where medication is insufficient, procedures like laser trabeculoplasty or trabeculectomy may be considered.

The prognosis for steroid-induced glaucoma largely depends on the timeliness of diagnosis and intervention. If detected early and managed effectively, patients can maintain good vision. However, if left untreated, the condition can lead to irreversible optic nerve damage and significant vision loss.

Steroid-induced glaucoma is caused by the use of corticosteroids, which can be administered in various forms, including eye drops, oral medications, inhalers, or topical creams. The risk of developing this condition is higher with prolonged use and higher doses of steroids.

The incidence of steroid-induced glaucoma varies, with some studies suggesting that up to 40% of individuals using topical steroids may experience elevated IOP. The risk is higher in individuals with a family history of glaucoma, those with pre-existing ocular hypertension, and certain ethnic groups.

Corticosteroids can affect the trabecular meshwork, the eye's drainage system, leading to reduced outflow of aqueous humor and increased intraocular pressure. This pressure can damage the optic nerve over time, resulting in glaucoma.

Preventing steroid-induced glaucoma involves careful monitoring and judicious use of corticosteroids. Patients on long-term steroid therapy should have regular eye exams to detect any changes in IOP early. When possible, using the lowest effective dose and considering alternative treatments can also reduce risk.

Steroid-induced glaucoma is a potential side effect of corticosteroid use, characterized by increased intraocular pressure and risk of optic nerve damage. Early detection and management are crucial to prevent vision loss. Regular eye examinations and careful use of steroids are key preventive measures.

If you are using corticosteroids, it's important to be aware of the potential risk of developing steroid-induced glaucoma. Regular eye check-ups can help detect any changes in eye pressure early. If you experience symptoms like blurred vision or eye pain, consult your healthcare provider promptly. Managing your medication and monitoring your eye health can help protect your vision.